Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Daily News

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

Todd Neale

November 08, 2016

Presentation TCT 2016

Surgically Implanted Sapien Valve in Mitral Annular Calcium: SITRAL Trial

Presenter: Michael J. Mack, Francesco Maisano, Robert L. Smith

October 30, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2016

Caitlin E. Cox

October 29, 2016

News Conference News EuroPCR 2016

As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease

Shelley Wood

May 18, 2016

News Conference News ACC 2012

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

March 24, 2012

News Daily News

Modified Transapical TAVR Technique Minimizes Paravalvular Regurgitation

March 23, 2012

News Daily News

Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’

Yael L. Maxwell

March 07, 2012

Presentation TCT 2012

Aortic valve calcium scoring (AVCS) is a predictor of significant paravalvular aortic insufficiency in transapical aortic valve implantation

Presenter: Martin Haensig, Lukas Lehmkuhl, David M. Holzhey, Chirojit Mukherjee, Joerg Kempfert, Thomas Walther, Axel Linke, Matthias Gutberlet, Ardawan J. Rastan, Friedrich W. Mohr

January 03, 2012

News Industry News

FDA approves first artificial aortic heart valve placed without open-heart surgery

November 02, 2011

Advertisement

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

Surgically Implanted Sapien Valve in Mitral Annular Calcium: SITRAL Trial

TCTMD’s Top 10 Most Popular Stories for October 2016

As Technique Inches Forward, Outcomes Improve for Transcatheter Treatment of Severe Calcific Mitral Disease

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

Modified Transapical TAVR Technique Minimizes Paravalvular Regurgitation

Studies Suggest 3-D CT Prior to TAVR Should Be ‘Gold Standard’

Aortic valve calcium scoring (AVCS) is a predictor of significant paravalvular aortic insufficiency in transapical aortic valve implantation

FDA approves first artificial aortic heart valve placed without open-heart surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content